Aptyx said its new Precision Extrusion Center of Excellence’s capabilities include high-precision tubing. [Photo courtesy of Aptyx]
“This marks another milestone in our growth strategy, further enhancing our ability to provide integrated expertise and innovation for our OEM life science customers,” Aptyx CEO and President Gregg Tobin said in a statement shared with Medical Design & Outsourcing ahead of the announcement. “This new center perfectly complements our Interventional Center of Excellence in Charlotte, where we have a long history of supporting complex transcatheter implants and delivery systems from early design to finished device manufacturing.”
The Precision Extrusion Center of Excellence will be near Boston at the Argos headquarters in Taunton, Massachusetts. Tempe, Arizona-based Aptyx said the deal “significantly expands [our] ability to serve the interventional and catheter-based device markets with speed, precision, and scalability.”
MDO Min-Vasive Medtech: Download our free 72-page special report featuring interviews with minimally invasive device development experts and engineers at major OEMs and groundbreaking startups
Argos was founded in 1997 by brothers John and Perry Cicalis, who refocused the company on small-diameter custom tubing in 2004 before moving into medical tubing, securing ISO 13485 certification in 2012 for its 25,000-square-foot facility at the Myles Standish Industrial Park, according to that company’s website.
They’ll continue to lead the business under Aptyx, Tobin said in an MDO interview after making the announcement.
“We’ve been building our interventional portfolio of capabilities, which includes transcatheter implants and delivery systems, and Argos has been really developing expertise in precision extrusion for a couple of decades,” he said. “Those capabilities align just perfectly with the existing portfolio that we have. So now, when you think about our interventional offering, we can provide extrusions, we can provide components, we can supply subassemblies and finished devices that include delivery systems as well as the complementary implants.”
The new center’s capabilities include high-precision tubing with wall thicknesses from .001 in. and inner diameter/outer diameter tolerances to .0005 in., multi-lumen, precise taper tubing, micro extrusions, co-extrusion, multi-layered extrusion, balloon tubing, quick-turn development and manufacturing in a controlled environment, and in-house tooling design to support speed, precision and risk mitigation, Aptyx said.
“We’re committed to conquering technical challenges and advancing what’s possible in medical tubing,” Aptyx Global Extrusion Director Patrick Daly said in the statement. “This expansion deepens our extrusion expertise and enhances how we bring specialized strengths together across Aptyx to drive medtech advancement.”
Private equity firm TruArc Partners purchased Aptyx — formerly known as Molded Devices Inc. (MDI) — in 2022 and rebranded the company in 2023. In January 2025, Aptyx purchased its Charlotte, North Carolina, operation from Medical Murray.
We’ll have more from our interview with Tobin at MDO soon. Sign up for our free email newsletter to be among the first to read the next article.
